Christopher Polk

616 total citations
18 papers, 244 citations indexed

About

Christopher Polk is a scholar working on Infectious Diseases, Epidemiology and Neurology. According to data from OpenAlex, Christopher Polk has authored 18 papers receiving a total of 244 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 9 papers in Epidemiology and 4 papers in Neurology. Recurrent topics in Christopher Polk's work include COVID-19 Clinical Research Studies (5 papers), Poxvirus research and outbreaks (3 papers) and Long-Term Effects of COVID-19 (3 papers). Christopher Polk is often cited by papers focused on COVID-19 Clinical Research Studies (5 papers), Poxvirus research and outbreaks (3 papers) and Long-Term Effects of COVID-19 (3 papers). Christopher Polk collaborates with scholars based in United States and Canada. Christopher Polk's co-authors include William E. Anderson, J. Wayne Meredith, Lisa Davidson, Catherine Passaretti, John Williamson, Avinash K. Shetty, Michael Leonard, Candice J. McNeil, John W. Sanders and Frank Cerasoli and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and CHEST Journal.

In The Last Decade

Christopher Polk

14 papers receiving 241 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher Polk United States 6 112 84 83 52 45 18 244
Safia Kuriakose United States 8 121 1.1× 98 1.2× 96 1.2× 55 1.1× 18 0.4× 16 243
Anne‐Lise Munier France 9 65 0.6× 12 0.1× 99 1.2× 37 0.7× 23 0.5× 21 200
P. Viale Italy 3 112 1.0× 61 0.7× 71 0.9× 33 0.6× 29 0.6× 3 202
Kévin Alexandre France 10 108 1.0× 68 0.8× 67 0.8× 15 0.3× 81 1.8× 23 316
Sirawat Srichatrapimuk Thailand 10 41 0.4× 19 0.2× 79 1.0× 21 0.4× 45 1.0× 22 269
Stefania Artioli Italy 8 121 1.1× 69 0.8× 136 1.6× 25 0.5× 16 0.4× 17 290
Aydın Deveci Türkiye 9 48 0.4× 26 0.3× 76 0.9× 7 0.1× 37 0.8× 32 218
Agathe Becker France 7 31 0.3× 26 0.3× 36 0.4× 23 0.4× 50 1.1× 14 172
Giorgio Mosconi Italy 7 68 0.6× 116 1.4× 76 0.9× 17 0.3× 44 1.0× 9 362
Nefise Öztoprak Türkiye 7 47 0.4× 28 0.3× 60 0.7× 26 0.5× 4 0.1× 15 138

Countries citing papers authored by Christopher Polk

Since Specialization
Citations

This map shows the geographic impact of Christopher Polk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Polk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Polk more than expected).

Fields of papers citing papers by Christopher Polk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Polk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Polk. The network helps show where Christopher Polk may publish in the future.

Co-authorship network of co-authors of Christopher Polk

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Polk. A scholar is included among the top collaborators of Christopher Polk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Polk. Christopher Polk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Leonard, Michael, et al.. (2023). 2674. Disparities in Mpox Care: Use of the Social Vulnerability Index to Predict Mpox Infections. Open Forum Infectious Diseases. 10(Supplement_2).
2.
Polk, Christopher, Michael Leonard, Lisa Davidson, et al.. (2023). Evaluation of a health system’s implementation of a monkeypox care model under the RE-AIM framework. Therapeutic Advances in Infectious Disease. 10. 2018393279–2018393279. 3 indexed citations
3.
Temesgen, Zelalem, Colleen F. Kelley, Frank Cerasoli, et al.. (2022). C reactive protein utilisation, a biomarker for early COVID-19 treatment, improves lenzilumab efficacy: results from the randomised phase 3 ‘LIVE-AIR’ trial. Thorax. 78(6). thoraxjnl–2022. 8 indexed citations
4.
Polk, Christopher, John Williamson, Avinash K. Shetty, et al.. (2022). Global monkeypox case hospitalisation rates: A rapid systematic review and meta-analysis. EClinicalMedicine. 54. 101710–101710. 36 indexed citations
5.
Anderson, William E., et al.. (2022). Outcomes and antibiotic use in patients with coronavirus disease 2019 (COVID-19) admitted to an intensive care unit. SHILAP Revista de lepidopterología. 2(1). e12–e12. 2 indexed citations
6.
7.
Polk, Christopher, et al.. (2022). Erdheim-Chester disease presenting as meningitis with hypoglycorrhachia: A case report. Medicine. 101(37). e30585–e30585. 2 indexed citations
8.
9.
Leonard, Michael, et al.. (2021). Implementation of a comprehensive intervention focused on hospitalized patients with HIV by an existing stewardship program: successes and lessons learned. Therapeutic Advances in Infectious Disease. 8. 2 indexed citations
10.
Temesgen, Zelalem, Charles D. Burger, Jason V. Baker, et al.. (2021). C-REACTIVE PROTEIN AS A BIOMARKER FOR IMPROVED EFFICACY OF LENZILUMAB IN PATIENTS WITH COVID-19: RESULTS FROM THE LIVE-AIR TRIAL. CHEST Journal. 160(4). A2522–A2524.
11.
Burger, Charles D., Jason V. Baker, Christopher Polk, et al.. (2021). 40. Lenzilumab Efficacy and Safety in Newly Hospitalized COVID-19 Subjects: Results From a Phase 3 Randomized Double-Blind Placebo-Controlled Trial. Open Forum Infectious Diseases. 8(Supplement_1). S29–S29.
12.
Polk, Christopher, et al.. (2020). Skin and Soft Tissue Infections in Patients with Diabetes Mellitus. Infectious Disease Clinics of North America. 35(1). 183–197. 51 indexed citations
13.
14.
Meredith, J. Wayne, et al.. (2020). Meropenem-Vaborbactam versus Ceftazidime-Avibactam for Treatment of Carbapenem-Resistant Enterobacteriaceae Infections. Antimicrobial Agents and Chemotherapy. 64(5). 122 indexed citations
15.
16.
Polk, Christopher, et al.. (2019). 1325. Inpatient Initiation of ART Improves Short-Term Mortality in People Living with HIV. Open Forum Infectious Diseases. 6(Supplement_2). S479–S479. 1 indexed citations
17.
Maćkowiak, P., Christopher Polk, Rudy J. Castellani, et al.. (2007). Encephalitis of the Basal Ganglia in an Injection Drug User. Clinical Infectious Diseases. 45(11). 1522–1524. 5 indexed citations
18.
Polk, Christopher, et al.. (2007). Cellulitis in a Patient with Leukemia. Clinical Infectious Diseases. 44(9). 1249–1250.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Safia Kuriakose Breakdown of academic impact, for papers by Anne‐Lise Munier Breakdown of academic impact, for papers by P. Viale Breakdown of academic impact, for papers by Kévin Alexandre Breakdown of academic impact, for papers by Sirawat Srichatrapimuk Breakdown of academic impact, for papers by Stefania Artioli Breakdown of academic impact, for papers by Aydın Deveci Breakdown of academic impact, for papers by Agathe Becker Breakdown of academic impact, for papers by Giorgio Mosconi Breakdown of academic impact, for papers by Nefise Öztoprak
Rankless by CCL
2026